BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23313930)

  • 1. Alzheimer's disease modeling: ups, downs, and perspectives for human induced pluripotent stem cells.
    Wojda U; Kuznicki J
    J Alzheimers Dis; 2013; 34(3):563-88. PubMed ID: 23313930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
    Grabel L
    J Cell Biochem; 2012 Feb; 113(2):381-7. PubMed ID: 21928325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling familial Alzheimer's disease with induced pluripotent stem cells.
    Yagi T; Ito D; Okada Y; Akamatsu W; Nihei Y; Yoshizaki T; Yamanaka S; Okano H; Suzuki N
    Hum Mol Genet; 2011 Dec; 20(23):4530-9. PubMed ID: 21900357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models.
    Sproul AA
    Mol Aspects Med; 2015; 43-44():54-65. PubMed ID: 26101165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises.
    Sanchez-Danes A; Benzoni P; Memo M; Dell'Era P; Raya A; Consiglio A
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1114-27. PubMed ID: 24040813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
    Gao A; Peng Y; Deng Y; Qing H
    Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amyloid peptide and its precursor in Alzheimer's disease.
    Octave JN
    Rev Neurosci; 1995; 6(4):287-316. PubMed ID: 8845971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem Cell Technology for (Epi)genetic Brain Disorders.
    Riemens RJM; Soares ES; Esteller M; Delgado-Morales R
    Adv Exp Med Biol; 2017; 978():443-475. PubMed ID: 28523560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside.
    Fan X; Sun D; Tang X; Cai Y; Yin ZQ; Xu H
    Med Res Rev; 2014 Sep; 34(5):957-78. PubMed ID: 24500883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.
    Tcw J
    Neurosci Lett; 2019 Apr; 699():31-40. PubMed ID: 30685408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for new animal models of Alzheimer's disease.
    Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
    Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell therapies for Alzheimer's disease: is it time?
    Wang SM; Lee CU; Lim HK
    Curr Opin Psychiatry; 2019 Mar; 32(2):105-116. PubMed ID: 30557266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone marrow stem cells to the rescue of Alzheimer's disease].
    Simard AR; Rivest S
    Med Sci (Paris); 2006 Oct; 22(10):822-4. PubMed ID: 17026932
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model.
    Lee JK; Jin HK; Bae JS
    Neurosci Lett; 2009 Jan; 450(2):136-41. PubMed ID: 19084047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
    Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM
    Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer's disease.
    Csöbönyeiová M; Polák Š; Danišovič L
    Rev Neurosci; 2016 Jul; 27(5):457-64. PubMed ID: 26812864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise review: Can stem cells be used to treat or model Alzheimer's disease?
    Chen WW; Blurton-Jones M
    Stem Cells; 2012 Dec; 30(12):2612-8. PubMed ID: 22997040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of amyloid-beta-related pathologies in Alzheimer's disease.
    Philipson O; Lord A; Gumucio A; O'Callaghan P; Lannfelt L; Nilsson LN
    FEBS J; 2010 Mar; 277(6):1389-409. PubMed ID: 20136653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing neural stem cell-based treatments for neurodegenerative diseases.
    Byrne JA
    Stem Cell Res Ther; 2014 May; 5(3):72. PubMed ID: 25157920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.